Health Reports Archive

Mental Health & Depression: 70 new trials, 3 Phase 3, 3,278 recruiting. Off Label Use tops 3,628 reports. July 20–27.

Cancer & Oncology: 189 new trials, 18,885 recruiting, 5 Phase 3. Off Label Use leads adverse reports at 8596. July 20–27.

Diabetes: 31 new trials, 1,971 recruiting, 394 papers published. Off-label use tops adverse reports at 10,229. July 20–27.

Heart Disease & Cardiovascular: 116 new trials, 8,821 recruiting, 1,070 papers published, fatigue tops adverse reports at 6,625, July 20–27

Dementia & Alzheimer’s: 11 new trials, 954 recruiting, 321 papers published, 628 death reports, July 20–27.

Mental Health & Depression: 71 new trials, 3,263 recruiting, 1,905 papers. Off Label Use tops adverse reports at 3,628. July 13–20.

Cancer & Oncology: 214 new trials, 18,845 recruiting, 3,726 papers published July 13–20, Off Label Use tops 8,596 reports.

Diabetes: 33 new trials, 1,960 recruiting, 1,515 papers. Off-label use tops adverse reports at 10,229. July 13–20.

Heart Disease & Cardiovascular: 120 new trials, 8,793 recruiting, 5 Phase 3. Fatigue tops adverse reports at 6,625. July 13–20.

Dementia & Alzheimer’s: 7 new trials, 958 recruiting, 1,410 papers published, 628 death reports. July 13–20.

All Reports